Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
about
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive reviewFactors regulating capillary remodeling in a reversible model of inflammatory corneal angiogenesisEvaluation of the Response to Ranibizumab Therapy following Bevacizumab Treatment Failure in Eyes with Diabetic Macular EdemaSubretinal AAV2.COMP-Ang1 suppresses choroidal neovascularization and vascular endothelial growth factor in a murine model of age-related macular degeneration.Osmotic Induction of Angiogenic Growth Factor Expression in Human Retinal Pigment Epithelial Cells.The regulatory role of hepatoma-derived growth factor as an angiogenic factor in the eye.Preliminary in vitro and in vivo assessment of a new targeted inhibitor for choroidal neovascularization in age-related macular degeneration.Aflibercept in refractory wet AMD treated with ranibizumab: Anatomical and visual outcome.Intake of dietary salt and drinking water: Implications for the development of age-related macular degeneration.Galectin-3 Inhibition by a Small-Molecule Inhibitor Reduces Both Pathological Corneal Neovascularization and Fibrosis.PDGF-CC underlies resistance to VEGF-A inhibition and combinatorial targeting of both suppresses pathological angiogenesis more efficiently.SYSTEMIC BETA-BLOCKERS IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.Therapeutic approaches for corneal neovascularization.Baseline Predictors of Visual Acuity Outcome in Patients with Wet Age-Related Macular Degeneration.
P2860
Q26744068-AAE53205-3FCC-4026-9CD2-8FD02BF422C7Q30804219-C8D91C75-54B3-4784-9EFC-5A8AEE6D53D1Q35171497-9D9ECD18-3082-48CE-B8C8-692664B241EEQ35896048-14EAE96A-2C50-46CC-9DA6-48078AACBB0FQ35901764-FDB456CA-B6F5-4FE5-AC7A-FFECB44D39C6Q36828146-ECB0A9AE-9FD3-4238-B964-5FC9A1793640Q37361488-A110967D-CDC5-446F-8040-BF45028F3F13Q37510774-7950E4F4-89BD-4CE0-B053-7D63DC1FB0D4Q37526810-1063D687-242D-4EFA-BF1B-84536F4248AEQ37579627-F27309CD-E8AB-49A3-B395-6B629EA8F18BQ37718460-B79B6A08-34DE-4C94-BE89-43FF2BD13B3EQ39550796-523E7E26-5B06-43EE-9E71-87DBA48ADF07Q47143268-7202C075-9CC3-4A73-AF36-43B17D627A45Q55289375-A67004D7-24BA-4060-A722-26A52E5C07AF
P2860
Resistance to antivascular endothelial growth factor treatment in age-related macular degeneration
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Resistance to antivascular end ...... e-related macular degeneration
@ast
Resistance to antivascular end ...... e-related macular degeneration
@en
Resistance to antivascular end ...... e-related macular degeneration
@nl
type
label
Resistance to antivascular end ...... e-related macular degeneration
@ast
Resistance to antivascular end ...... e-related macular degeneration
@en
Resistance to antivascular end ...... e-related macular degeneration
@nl
prefLabel
Resistance to antivascular end ...... e-related macular degeneration
@ast
Resistance to antivascular end ...... e-related macular degeneration
@en
Resistance to antivascular end ...... e-related macular degeneration
@nl
P2093
P2860
P921
P3181
P356
P1476
Resistance to antivascular end ...... e-related macular degeneration
@en
P2093
Ilias Georgalas
Solon Asteriades
Vachtsevanos
P2860
P304
P3181
P356
10.2147/DDDT.S43470
P407
P577
2013-01-01T00:00:00Z
2013-06-17T00:00:00Z